Nems/Mems Works LLC is categorized under Commercial Biotechnical Research in Columbia, MO and active since 2004.
Nems/Mems Works LLC was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Keshab Gangopadhyay at the company’s single location by writing to 410 South 6th St, Columbia, Missouri MO 65211 or by phoning (573) 356-9459. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Nems/Mems Works LLC |
Contact Person: | Keshab Gangopadhyay |
Address: | 410 South 6th St, Columbia, Missouri 65211 |
Phone Number: | (573) 356-9459 |
Website Address: | nemsmems.org |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 541711 |
Share This Business: |
Nems/Mems Works LLC was started in 2004 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Keshab Gangopadhyay for inquiries that concern Nems/Mems Works LLC by calling the company number (573) 356-9459, as your correspondence is most welcome. Additionally, the physical location of the single location of Nems/Mems Works LLC can be found at the coordinates 38.946064,-92.33076 as well as the street address 410 South 6th St in Columbia, Missouri 65211.
For its online presence, you may visit Nems/Mems Works LLC’s website at nemsmems.org and engage with its social media outlets through on Twitter and on Facebook.